A new genetic testing service now enables parents using in vitro fertilization (IVF) to rank embryos based on their predicted lifespan and disease risk.
For $6,000, Nucleus Genomics offers to analyze up to 900 conditions, including cancer, heart disease, and even IQ and height.
While framed as a scientific advance, this practice marks a disturbing shift: human lives reduced to data, with embryos discarded for not meeting projected standards.
Read more here.